Aripiprazole reduces alcohol use [7]

Canadian Journal of Psychiatry

Volumn 50, Issue 4, 2005, Pages 244-

  Warsi, Mustafa ^a   Sattar, S Pirzada ^a   Bhatia, Subhash C ^a   Petty, Frederick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; OLANZAPINE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ALCOHOLISM; ANXIETY DISORDER; DISEASE EXACERBATION; DOPAMINERGIC ACTIVITY; DRUG MECHANISM; GLAUCOMA; HUMAN; LETTER; NUCLEUS ACCUMBENS; PARANOIA; SCHIZOPHRENIA; ADULT; CASE REPORT; DRINKING BEHAVIOR; MALE;

ADULT; ALCOHOL DRINKING; ANTIPSYCHOTIC AGENTS; HUMANS; MALE; PIPERAZINES; QUINOLONES;

EID: 20344378688     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370505000415     Document Type: Letter

References (7)

1. Sattar SP, Grant K, Bhatia SC, Petty F. Potential use of quetiapine in treatment of substance dependence disorders. J Psychiatry Neurosci 2004;29:452-7.
2. Argo TR, Carnahan RM, Perry PJ. Aripiprazole, a novel atypical antipsychotic drug. Pharmacotherapy 2004;24:212-28.
3. Pilla M, Pearchon S, Sautel F, Garrido F, Mann A, Wermuth CG, and others. Selective inhibition of cocaine-seeking behavior by a partial dopamine D-3 receptor agonist. Nature 1999;400:371-5.
4. Bowers MB Jr, Mazure CM, Nelson JC, Jatlow DI. Pyschogenic drug use and neuroleptic response. Schizophr Bull 1990;16:81-5.
5. Sirrius SG. Pharmacologic treatment of substance abusing Schizophrenia patients. Schizophr Bul. 1990;16:111-22.
6. McEvoy JP, Freudenreich O, Levin ED, Rose JE. Haloperidal increases smoking in patients with schizophrenia. Psychopharmacol 1995;119:124-6.
7. Green AI, Zimmet SV, Strous RD, Schildkraut JJ. Clozapine for co-morbid substance use disorder and schizophrenia: do patients with schizophrenia have a higher reward deficiency syndrome that can be ameliorated by clozapine. Harv Rev Psychiatry 1999;6:287-96.